CVE-2022-26238The default privileges for the running service Normand Service Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows non-privileged users to overwrite and manipulate executables and l…
Updated under an hour ago ()
Does this affect you?
It affects beckmancoulter remisol_advance. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.21%, higher than 10% of scored CVEs.
Do this next
Free account, 1 product
The default privileges for the running service Normand Service Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows non-privileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.
- CVSS
- 5.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.21% (percentile 10)
- Assigned by
- mitre
- NVD analysis
- Modified
- Record last updated
- Aug 3, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
beckmancoulter remisol_advance beckmancoulter:remisol_advance | through 2.0.12.1 | NVD |
References
- https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advanceproduct
- https://pastebin.com/23N5wcC7third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.